TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2017

A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach.

Kednapa Thavorn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.